VIR-1388: Clinical Trial of Preventive HIV Vaccine Begins

Novel vaccine includes NIH-funded technology in development since 2004. A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa. The Phase 1 trial will evaluate a novel vaccine known as VIR-1388 for its safety and ability to induce an HIV-specific